Projects

RNDr. Katarína Lopušná, PhD.

International

Current
  • Alliance4Life Bridging the Research and Innovation Gap in Life Sciences
    Program: Horizon Europe
    Duration: 1. 3. 2024 – 29. 2. 2028
Finished
  • A4L_BRIDGE The role and mutational profile of immune checkpoint molecules in hematologic malignancies
    Program: Other
    Duration: 1. 11. 2024 – 31. 10. 2025
  • A4L_ACTIONS Immune checkpoint molecules in hematologic malignancies
    Program: Other
    Duration: 1. 11. 2022 – 31. 10. 2023

National

Current
  • Immune checkpoint BTLA as a potential biomarker in the therapy of diffuse large B-cell lymphoma
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
  • New methods of detection of subtypes of selected herpesviruses in patients with hematological malignancies in Slovakia
    Program: PostdokGrant
    Duration: 1. 7. 2024 – 31. 12. 2025
Finished
  • Checkpoint molecules and viral immunomodulators in cancer therapy
    Program: SASPRO
    Duration: 1. 9. 2022 – 31. 8. 2025
  • Herpesviral immunomodulators as novel candidates in therapy of cancer and inflammatory diseases
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Monitoring of tick saliva immunomodulators effects on innate antiviral responses of skin
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Imunomodulatory properties of the murine herpesvirus M3 protein and the role of ticks in herpesvirus circulation in nature
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • The role of vitamin D and interferons type III in gammaherpesvirus oncogenesis
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
Employees